Viewing results 1 - 6 of 2
On October 24, the Swiss pharmaceutical giant F. Hoffmann-La Roche Ltd., in partnership with Nobel Almaty Pharmaceutical Factory JSC, launched the production of innovative drugs in Almaty. The project followed an agreement between Roche, Kazakhstan’s SK-Pharmacy LLP, Nobel, and the Kazakh Research Institute of Oncology and Radiology, with the support of National Company Kazakh Invest. Under the agreement, Roche committed to establishing local production of three biotechnological drugs for the treatment of HER2-positive breast cancer, an aggressive form of the disease that affects up to 20% of breast cancer patients in Kazakhstan. At the opening ceremony, Kazakhstan's Minister of Health, Akmaral Alnazarova, said: "The localization [of production] of oncological drugs by a global leader like Roche is a huge step forward for our country. This project will provide patients access to advanced treatments and significantly contribute to developing Kazakhstan's healthcare infrastructure.” The transfer of Roche's advanced technologies and production capabilities to local partners will reduce healthcare system costs in Kazakhstan and significantly expand patient access to essential medicines. Around 5,000 new cases of breast cancer are registered in the country annually, with approximately 1,200 resulting in death. This project is expected to increase the number of patients receiving therapy to 1,335 by 2026. The project is part of Kazakhstan’s plan to increase the share of domestically produced medicines and medical devices to 50%.
Kyrgyzstan's Health Ministry has devised an initiative to legalize traditional folk medicine. A draft decree of the Cabinet of Ministers on the procedure for training specialists has now been submitted for public discussion. Proposed by Minister of Health Alymkadyr Beishenaliev, the initiative concerns the study of traditional healing methods such as phytotherapy, massage, acupuncture, apitherapy, and hippotherapy, conducted through specialist training programs. He has also mooted the establishment of a research institute or Academy of Traditional Kyrgyz Medicine offering courses in theoretical and practical skills taught by professionals in the field, alongside the foundation of a dissertation council for the defense of academic degrees in the discipline. Central to the project, is the introduction of a budget for traditional medicine specialists, such as acupuncturists and physiotherapists, in all medical institutions of the country. There are also plans to open a research institute to test the efficacy of medicinal plants and conduct clinical trials. In addition, the Cabinet of Ministers has proposed the implementation of medicinal herb plantations for the subsequent production of related medical drugs. It is worth noting that in both several former Soviet Union and countries worldwide, traditional medicine has been legalized and integrated into state healthcare systems. For example, Russia and Belarus practice traditional treatments, including phytotherapy, acupuncture, alongside modern medical procedures. Traditional Chinese medicine is widely practiced in China, Japan, and Korea, and Ayurveda and Yunani are actively being developed in India. The World Health Organization also supports the development of traditional medicine by helping countries develop recognized international standards.
